FTC Files Legal Action Against Amare Global
The Federal Trade Commission (FTC) has filed a lawsuit against Amare Global, accusing the company of making misleading health and income claims to promote its products and business opportunity.
According to the complaint filed in California on June 2, 2026, the FTC alleges that Amare Global marketed its products using unsupported claims related to mental wellness. The agency also claims that the company made deceptive earnings representations that may have misled consumers and distributors.
Mental Wellness Claims Under Scrutiny
Amare Global has long branded itself as “The Mental Wellness Company” and promotes a product category it calls “Mentabiotics.” Regulators argue that the company failed to provide adequate scientific evidence to support several of its health-related marketing claims.
The FTC alleges that consumers were led to believe that Amare Global products could significantly improve mental wellness, despite a lack of reliable proof supporting those statements.
Previous Concerns About Product Marketing
Industry watchdogs and critics have previously questioned Amare Global’s health claims. Reviews published over the years highlighted concerns about the company’s emphasis on mental wellness benefits without presenting sufficient scientific validation.
The latest FTC action marks a significant regulatory challenge for the company and could have broader implications for how wellness-focused MLM companies market their products.
Company Ownership and Leadership Changes
At the time of earlier reviews in 2023, Amare Global was led by founder Hiep Tran and CEO Jared Turner. In January 2024, the company was acquired by David C. Chung, marking a major ownership transition.
